Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Winston

Showing results (201-210 of 373) with videos related to

Pageof 38
Sort By:
Human Reproduction (Oxford, England)|January 1, 1991
The incidence of abnormal morphology and nucleocytoplasmic ratios in 2-, 3- and 5-day human pre-embryosN J Winston, P R Braude, S J Pickering, et al.
Annals of Internal Medicine|January 1, 1987
Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantationD J Winston, W G Ho, C H Lin, et al.
The Journal of Infectious Diseases|July 30, 2020
Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral TherapyNina Singh, Drew J Winston, Raymund R Razonable, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 8, 2014
Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipientsD J Winston, A P Limaye, S Pelletier, et al.
Environmental Science & Technology|July 30, 2024
Occurrence, Concentration, and Distribution of 35 PFASs and Their Precursors Retained in 20 Stormwater BiofiltersAli Beryani, Robert Furén, Heléne Österlund, et al.
The Journal of Infectious Diseases|March 23, 2021
Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral TherapyNina Singh, Drew J Winston, Raymund R Razonable, et al.
Annals of Internal Medicine|February 1, 1993
Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trialD J Winston, W G Ho, K Bartoni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 27, 2020
Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive DonorsNina Singh, Drew J Winston, Raymund R Razonable, et al.
Immunitat Und Infektion|November 1, 1985
[Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation]D J Winston, W G Ho, G H Lin, et al.
Journal of Clinical Immunology|April 1, 1982
Use of intravenous immune globulin in patients receiving bone marrow transplantsD J Winston, W G Ho, L E Rasmussen, et al.
Pageof 38

Showing results (201-210 of 373) with videos related to

Sort By:
Pageof 38
Human Reproduction (Oxford, England)|January 1, 1991
The incidence of abnormal morphology and nucleocytoplasmic ratios in 2-, 3- and 5-day human pre-embryosN J Winston, P R Braude, S J Pickering, et al.
Annals of Internal Medicine|January 1, 1987
Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantationD J Winston, W G Ho, C H Lin, et al.
The Journal of Infectious Diseases|July 30, 2020
Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral TherapyNina Singh, Drew J Winston, Raymund R Razonable, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 8, 2014
Randomized, double-blind trial of anidulafungin versus fluconazole for prophylaxis of invasive fungal infections in high-risk liver transplant recipientsD J Winston, A P Limaye, S Pelletier, et al.
Environmental Science & Technology|July 30, 2024
Occurrence, Concentration, and Distribution of 35 PFASs and Their Precursors Retained in 20 Stormwater BiofiltersAli Beryani, Robert Furén, Heléne Österlund, et al.
The Journal of Infectious Diseases|March 23, 2021
Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral TherapyNina Singh, Drew J Winston, Raymund R Razonable, et al.
Annals of Internal Medicine|February 1, 1993
Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trialD J Winston, W G Ho, K Bartoni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 27, 2020
Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive DonorsNina Singh, Drew J Winston, Raymund R Razonable, et al.
Immunitat Und Infektion|November 1, 1985
[Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation]D J Winston, W G Ho, G H Lin, et al.
Journal of Clinical Immunology|April 1, 1982
Use of intravenous immune globulin in patients receiving bone marrow transplantsD J Winston, W G Ho, L E Rasmussen, et al.
Pageof 38